Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …
substantially over the past decades. However, the potential risk of cardiovascular disease …
ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases
Background Although often intended for long-term treatment, discontinuation of medication
for ADHD is common. However, cross-national estimates of discontinuation are missing due …
for ADHD is common. However, cross-national estimates of discontinuation are missing due …
Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update
Low medication-adherence and persistence may reduce the effectiveness of ADHD-
medication. This preregistered systematic review (PROSPERO CRD42020218654) on …
medication. This preregistered systematic review (PROSPERO CRD42020218654) on …
Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort study
Objective To determine longitudinal patterns of dispensing of antidepressant, anxiolytic,
antipsychotic, psychostimulant, and hypnotic/sedative medications to children and …
antipsychotic, psychostimulant, and hypnotic/sedative medications to children and …
Psychotogenic potential of prescribed drugs
Australian & New Zealand Journal of Psychiatry, 00 (0) with this, increased risk for
development of psychosis is observed in populations prescribed amphetamines, including …
development of psychosis is observed in populations prescribed amphetamines, including …
Incidence of ADHD medication use among Finnish children and adolescents in 2008–2019: a need for practice changes?
TA Kolari, M Vuori, H RÄttÖ… - … Journal of Public …, 2024 - journals.sagepub.com
Aims: This study examined the incidence of attention-deficit/hyperactivity disorder
medication among children and adolescents by sex and age group in Finland during 2008 …
medication among children and adolescents by sex and age group in Finland during 2008 …
Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013–2022
Objective People living with cystic fibrosis (PwCF) are at increased risk of mental health
conditions. There is little evidence addressing psychotropic medication use in PwCF. This …
conditions. There is little evidence addressing psychotropic medication use in PwCF. This …
A model of care for attention deficit and hyperactivity disorder among adults in the community
S Suetani, J Hull, L Zeniou, L Chong… - Australasian …, 2023 - journals.sagepub.com
Objective To describe the process of collaborative, contextualised development and
implementation of a model of care for adults with symptoms suggestive of attention deficit …
implementation of a model of care for adults with symptoms suggestive of attention deficit …
Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis
Methods Services Australia maintains a dataset that includes all PBS dispensing claims for a
randomly selected 10% sample of PBS-eligible Australians. We used the PBS 10% sample …
randomly selected 10% sample of PBS-eligible Australians. We used the PBS 10% sample …
Guanfacine Used With Antipsychotics May Cause Bradycardia to Become Apparent After Discontinuation of Antipsychotics
T Murata, K Uno, T Nagamine - American Journal of Therapeutics, 2024 - journals.lww.com
Guanfacine Used With Antipsychotics May Cause Bradycardia to Become Apparent After
Discontinuation of Antipsychotics ammonia caused by chemotherapy include enhanced …
Discontinuation of Antipsychotics ammonia caused by chemotherapy include enhanced …